Back to mobile site

Northland Capital Markets Downgrades Edwards Lifesciences (EW) to Market Perform

April 25, 2018 8:12 AM EDT Send to a Friend
Northland Capital Markets downgraded Edwards Lifesciences (NYSE: EW) from Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login